--- title: Could hormonal changes and immune problems explain menstrual issues in autistic women? description: This paper proposes that autistic women may experience severe menstrual and reproductive health problems because their immune cells react strongly to hormonal url: https://niyora.com/research/papers/autism-spectrum-disorder-as-a-developmental-autoimmune-condition-a-neural-crest-2026/ --- - [Niyora](https://niyora.com/) - [Research](https://niyora.com/research/) - [Library](https://niyora.com/research/library/) - Could hormonal changes and immune problems explain menstrual issues in autistic women? Survey study, 2026 # Could hormonal changes and immune problems explain menstrual issues in autistic women? This paper proposes that autistic women may experience severe menstrual and reproductive health problems because their immune cells react strongly to hormonal changes during menstruation and pregnancy. This proposed connection has not yet been tested. Early or limited evidence Individuals with autism spectrum disorder, especially those with PMDD and endometriosis ## What they did This paper presents a theoretical model connecting autism, immune system function, genetic factors, and reproductive health. It proposes that autistic women are a key population for understanding how hormones and immune cells might interact. ## What they found The paper outlines a proposed mechanism where genetic variation (MTHFR C677T), childhood immune challenges, and disrupted development create vulnerability to inflammation. In autistic women, interactions between immune cells and hormonal changes during menstruation might trigger increased inflammation, potentially explaining severe premenstrual symptoms and endometriosis. ## What it means for you If correct, this could explain why some autistic women experience severe menstrual and reproductive problems. However, this is a proposed model that needs to be tested in actual research. Current findings are theoretical, not based on completed studies. ## About the study Original title Autism Spectrum Disorder as a Developmental Autoimmune Condition: A Neural Crest, Immune Dysregulation, and Hormonal-Inflammatory Model Authors Nathania Sailor Year 2026 Study design Survey study Open access Yes Read the paper [doi.org/10.17605/osf.io/atqd6](https://doi.org/10.17605/osf.io/atqd6) Original abstract Research Question: Is autism spectrum disorder better understood as a developmental autoimmune condition, in which early childhood immune dysregulation — driven by genetic susceptibility, particularly MTHFR C677T polymorphism, and environmental triggers including maternal immune activation, gut dysbiosis, and antibiotic exposure — initiates a progressive, systemic inflammatory cascade originating in disrupted neural crest development that produces both the behavioral phenotype and the later-life comorbidities affecting connective tissue, autonomic function, immune regulation, and reproductive health — with autistic women representing the highest-signal population for understanding this mechanism due to the interaction between constitutively hyperreactive mast cells and hormonal fluctuation across the lifespan? PICO Breakdown: Population: Individuals with autism spectrum disorder, with particular attention to: • Those diagnosed later in life • Those assigned female at birth • Those with comorbid hypermobility spectrum disorder, hEDS, POTS, and MCAS • Those with comorbid PMDD and endometriosis • Siblings with variable phenotypic expression within the same family Exposure — the proposed causal mechanism: A convergence of: • MTHFR C677T polymorphism impairing methylation capacity in a nutritionally or immunologically compromised intrauterine environment • Disrupted neural crest cell migration and differentiation during critical embryological windows producing a vulnerable multi-system terrain — characterized by lax connective tissue, autonomic susceptibility, and constitutively hyperreactive mast cells • Early childhood immune challenges including maternal immune activation during pregnancy, recurrent infections, broad-spectrum antibiotic exposure, and gut dysbiosis • In a body with this vulnerable terrain these immune hits do not resolve fully but initiate a chronic low-grade self-reinforcing neuroinflammatory cascade • In autistic women specifically — estrogen’s biphasic relationship with mast cell activation creates windows of inflammatory vulnerability at every hormonal milestone: menarche, luteal phase, pregnancy, perimenopause Outcome — what results: A chronic self-reinforcing inflammatory state that progressively affects: • Neurological development — producing the behavioral phenotype as output of inflammation rather than primary brain disorder • Sensory processing — via microglial priming and altered synaptic pruning • Autonomic regulation — dysautonomia, POTS, chronic sympathetic dominance • Immune function — MCAS, elevated cytokines, gut permeability, microbial translocation • Connective tissue integrity — hEDS, hypermobility spectrum disorder • Reproductive health in autistic women — PMDD as luteal phase mast cell crisis, endometriosis as peritoneal mast cell driven inflammation • Intellectual disability in a subset — as a potential neurological scar of early inflammatory burden reaching critical developmental windows at sufficient intensity • Variable phenotypic expression across siblings — determined by differences in intrauterine inflammatory environment, timing of developmental hits, and sex-mediated hormonal buffering The central question is therefore: Does the existing evidence across immunology, neurodevelopment, connective tissue biology, reproductive medicine, and epigenetics support reclassifying autism spectrum disorder as a developmental autoimmune condition — and does the physiological comorbidity profile of autistic women, when examined as an integrated hormonal-immune system rather than a collection of coincidental diagnoses, provide the clearest available evidence for this reclassification? We propose that autism spectrum disorder originates in disrupted neural crest development under conditions of genetic methylation vulnerability and intrauterine immune dysregulation, producing a multi-system inflammatory terrain that expresses as behavioral phenotype in early childhood and progressive autonomic, immune, connective tissue, and reproductive pathology across the lifespan — with autistic women representing the most diagnostically legible population for understanding this mechanism because hormonal fluctuation across their lifespan continuously stress-tests and reveals the underlying inflammatory architecture that male-default research design has systematically failed to examine. Reproduced under CC-BY. ## Topics [Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Menstrual cycle and mood](https://niyora.com/research/topics/condition-cycle-mood/)[Autism](https://niyora.com/research/topics/comorbidity-autism/)[Pregnancy and postpartum](https://niyora.com/research/topics/comorbidity-postpartum/)[Endometriosis](https://niyora.com/research/topics/comorbidity-endometriosis/)[Work and productivity](https://niyora.com/research/topics/life-area-work/)[Quality of life and daily functioning](https://niyora.com/research/topics/life-area-quality-of-life/) Research tells you what helps on average. Niyora helps on the day it hits. Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor. ## Related studies Survey study, 2022 What are the biggest research gaps in women's health, especially for menstrual conditions? Systematic review, 2026 What do we know about PMDD in autistic people and those with ADHD? Randomised trial, 2023 What does research show about PMDD neurochemistry? Systematic review, 2026 Why do some women experience mood changes linked to their menstrual cycle? Survey study, 2022 What causes PMS and PMDD and what new treatments are being studied? Survey study, 2026 Do people with ADHD traits have higher rates of PMDD than others? Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗